NMN Research

Nicotinamide mononucleotide (NMN) is a compound the body uses to make NAD+, a coenzyme involved in how cells produce energy. Human research on NMN is at an early stage, and most studies so far have been small and short.

Research summaries are for information only; they are not claims about Charava products.

Below is a list of some of the interesting research and clinical trials on Nicotinamide Mononucleotide. 

• Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects
• Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
• Effect of NMN in healthy Japanese men
• The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
• Efficacy study in prediabetic, post-menopausal, obese or overweight women, demonstrating increase in insulin sensitivity. Same study showed NMN is stimulating the collagen production pathway.
• Efficacy study in elderly men (over 65), showing protection against age-related muscle loss 
• Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study
• Efficacy study in healthy adults showing improved cardiovascular fitness, increased aerobic capacity and endurance in amateur runners 
• Efficacy study in humans and mice showing lengthening of telomeres in a dose dependent manner after 30, 45 and 60 days
• Nicotinamide Mononucleotide Is Safely Metabolized and Significantly Reduces Blood Triglyceride Levels in Healthy Individuals
• Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women
• Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study

For more details, please refer to PubMed.